15 enero 2022

Echocardiographic Assessment of Melody Versus Sapien Valves Following Transcatheter Pulmonary Valve Replacement

Juan Carlos Samayoa, Dana Boucek, Elisa McCarthy, Michelle Riley, Zhining Ou, Lloyd Y. Tani, Arvind K. Hoskoppal, Robert G. Gray, and Mary Hunt Martin

Objectives The aim of this study was to compare the immediate and midterm echocardiographic performance of the Melody (Medtronic Inc) and Sapien (Edwards Lifesciences Inc) valves after transcatheter pulmonary valve replacement (TPVR) in native and conduit right ventricular outflow tracts (RVOTs).

15 enero 2022

Permanent Pacemaker Reduction Using Cusp-Overlapping Projection in TAVR: A Propensity Score Analysis

Isaac Pascual, Daniel Hernández-Vaquero, Alberto Alperi, Marcel Almendarez, Pablo Avanzas, Dimitri Kalavrouziotis, Rebeca Lorca, Jules Mesnier, Luis Arboine, Siamak Mohammadi, Raquel del Valle, Eric Dumont, Victor Leon, Robert De Larochelliere, Josep Rodés-Cabau, and Cesar Moris

Objectives The aim of this study was to determine if modifying the classical implantation technique for self-expanding (SE) transcatheter aortic valve replacement to a novel cusp-overlapping projection (COP) technique results in a higher implantation depth (ID) and subsequently reduces the rate of permanent pacemaker implantation (PPMI).

15 enero 2022

Commissural Versus Coronary Optimized Alignment During Transcatheter Aortic Valve Replacement

Alfredo Redondo, Carlos Baladrón Zorita, Didier Tchétché, Sandra Santos-Martinez, Jose Raúl Delgado-Arana, Alejandro Barrero, Hipólito Gutiérrez, Ana Serrador Frutos, Cristina Ybarra Falcón, Mario García Gómez, Manuel Carrasco Moraleja, Teresa Sevilla, Israel Sanchez Lite, Esther Sanz, J. Alberto San Román, and Ignacio J. Amat-Santos

Objectives The aims of this study were to determine the rate of noncentered coronary ostia and their risk for coronary overlap (CO) and to develop an improved orientation strategy for transcatheter aortic valve replacement (TAVR) devices taking into account anatomical cues to identify patients at risk for CO regardless of commissural alignment and compute an alternative, CO-free TAVR rotation angle for those patients.

15 enero 2022

Cusp Symmetry and Coronary Ostial Eccentricity and its Impact on Coronary Access Following TAVR

Xi Wang, Ole De Backer, Gintautas Bieliauskas, Ivan Wong, Vilhelmas Bajoras, Tian-Yuan Xiong, Yi Zhang, Klaus Fuglsang Kofoed, Mao Chen, and Lars Sondergaard

Objectives The aim of this study was to assess cusp symmetry and coronary ostial eccentricity and its impact on coronary access following transcatheter aortic valve replacement (TAVR) using a patient-specific commissural alignment implantation technique.

15 febrero 2022

Postprocedure Anticoagulation in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Yan Yan, Wei Gong, Changsheng Ma, Xiao Wang, Sidney C. Smith, Gregg C. Fonarow, Louise Morgan, Jing Liu, Eric Vicaut, Dong Zhao, Gilles Montalescot, Shaoping Nie, and on behalf of the CCC-ACS Investigators

Objectives This study sought to assess the association between postprocedural anticoagulation (PPAC) use and several clinical outcomes.

15 febrero 2022

Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes

Claudio Laudani, Antonio Greco, Giovanni Occhipinti, Salvatore Ingala, Dario Calderone, Lorenzo Scalia, Federica Agnello, Marco Legnazzi, Maria Sara Mauro, Carla Rochira, Sergio Buccheri, Roxana Mehran, Stefan James, Dominick J. Angiolillo, and Davide Capodanno

Objectives The aim of this study was to compare short dual antiplatelet therapy (DAPT) and de-escalation in a network meta-analysis using standard DAPT as common comparator.

15 febrero 2022

Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy

Mauro Chiarito, Usman Baber, Davide Cao, Samin K. Sharma, George Dangas, Dominick J. Angiolillo, Carlo Briguori, David J. Cohen, Dariusz Dudek, Vladimír Džavík, Javier Escaned, Robert Gil, Christian W. Hamm, Timothy Henry, Kurt Huber, Adnan Kastrati, Upendra Kaul, Ran Kornowski, Mitchell Krucoff, Vijay Kunadian, Shamir R. Mehta, David Moliterno, E. Magnus Ohman, Keith Oldroyd, Gennaro Sardella, Zhang Zhongjie, Samantha Sartori, Giulio Stefanini, Richard Shlofmitz, P. Gabriel Steg, Giora Weisz, Bernhard Witzenbichler, Ya-ling Han, Stuart Pocock, C. Michael Gibson, and Roxana Mehran

Objectives The aim of this study was to evaluate if patients with prior myocardial infarction (MI) could benefit from ticagrelor monotherapy in terms of bleeding reduction without any compromise in ischemic event prevention.

15 abril 2022

Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: An ADAPT-DES Substudy

Reza Mohebi, Keyvan Karimi Galougahi, Javier Jas Garcia, Jennifer Horst, Ori Ben-Yehuda, Jai Radhakrishnan, Glenn M. Chertow, Allen Jeremias, David J. Cohen, David J. Cohen, Akiko Maehara, Gary S. Mintz, Shmuel Chen, Björn Redfors, Martin B. Leon, Thomas D. Stuckey, Michael J. Rinaldi, Giora Weisz, Bernhard Witzenbichler, Ajay J. Kirtane, Roxana Mehran, George D. Dangas, Gregg W. Stone, and Ziad A. Ali

Objectives This study sought to determine correlates and consequences of contrast-associated acute kidney injury (CA-AKI) on clinical outcomes in patients with or without pre-existing chronic kidney disease (CKD).

15 abril 2022

Treatment of Coronary De Novo Lesions by a Sirolimus- or Paclitaxel-Coated Balloon

Wan Azman Wan Ahmad, Amin Ariff Nuruddin, Muhamad Ali S.K. Abdul Kader, Tiong Kiam Ong, Houng Bang Liew, Rosli Mohd Ali, Ahmad Syadi Mahmood Zuhdi, Muhammad Dzafir Ismail, Ahmad K.M. Yusof, Carsten Schwenke, Maren Kutschera, and Bruno Scheller

Objectives The aim of this randomized controlled trial was to investigate a novel sirolimus-coated balloon (SCB) compared with the best investigated paclitaxel-coated balloon (PCB).

15 abril 2022

Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary Intervention

Björn Redfors, Ajay J. Kirtane, Mengdan Liu, Daniel R. Musikantow, Bernhard Witzenbichler, Michael J. Rinaldi, D. Christopher Metzger, Giora Weisz, Thomas D. Stuckey, Bruce R. Brodie, Ori Ben-Yehuda, Roxana Mehran, and Gregg W. Stone

Objectives The purpose of this study was to assess the extent to which the association between premature dual antiplatelet therapy (DAPT) discontinuation and excess risk of thrombotic events varies according to the reason and timing of DAPT discontinuation and whether high on-treatment platelet reactivity (HPR) influences the risk of thrombotic events after premature DAPT discontinuation.

15 abril 2022

Radial Hemostasis Is Facilitated With a Potassium Ferrate Hemostatic Patch: The STAT2 Trial

Jordan G. Safirstein, David M. Tehrani, Jeffrey M. Schussler, Nicole Reid, Kush Mukerjee, Larissa Weber, Henry Liu, Shea Skenderian, Michael Simeon, Tyler Yang, and Arnold H. Seto

Objectives The aim of this trial was to test whether the potassium ferrate hemostatic patch (PFHP) as an adjunct to the TR Band (TRB) facilitated an early deflation protocol.

15 abril 2022

Femoral or Radial Approach in Treatment of Coronary Chronic Total Occlusion: A Randomized Clinical Trial

Sevket Gorgulu, Nihat Kalay, Tugrul Norgaz, Cuneyt Kocas, Omer Goktekin, and Emmanouil S. Brilakis

Objectives The aim of this study was to compare transradial access (TRA) with transfemoral access (TFA) for chronic total occlusion (CTO) percutaneous coronary intervention (PCI).

15 abril 2022

Retrograde Chronic Total Occlusion Percutaneous Coronary Interventions: Predictors of Procedural Success From the ERCTO Registry

Aung Myat, Alfredo R. Galassi, Gerald S. Werner, Kambis Mashayekhi, Alexandre Avran, Nicolas Boudou, Markus Meyer-Gessner, Nicolaus Reifart, Maciej Lesiak, Roberto Garbo, Alexander Bufe, James Spratt, Leszek Bryniarski, Evald H. Christiansen, Georgios Sianos, Javier Escaned, Carlo di Mario, and David Hildick-Smith

Objectives The aim of this study was to identify independent predictors of procedural success after retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI).

15 abril 2022

EROSION III: A Multicenter RCT of OCT-Guided Reperfusion in STEMI With Early Infarct Artery Patency

Haibo Jia, Jiannan Dai, Luping He, Yishuo Xu, Yongfeng Shi, Lei Zhao, Zhiqi Sun, Yin Liu, Ziqian Weng, Xue Feng, Dirui Zhang, Tao Chen, Xiling Zhang, Lulu Li, Yousheng Xu, Yanqing Wu, Yining Yang, Chunmei Wang, Lang Li, Jianping Li, Jingbo Hou, Bin Liu, Gary S. Mintz, and Bo Yu

Objectives The aim of this study was to test whether optical coherence tomographic (OCT) guidance would provide additional useful information beyond that obtained by angiography and lead to a shift in reperfusion strategy and improved clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) with early infarct artery patency.

15 abril 2022

Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus After Anterior ST-Segment Elevation Myocardial Infarction

Zhongfan Zhang, Daoyuan Si, Qian Zhang, Lina Jin, Haikuo Zheng, Ming Qu, Miao Yu, Zhenya Jiang, Delin Li, Souping Li, Ping Yang, Yuquan He, and Wenqi Zhang

Objectives The aim of this study was to investigate the effects of rivaroxaban on left ventricle thromboprophylaxis in patients with anterior ST-segment elevation myocardial infarction (STEMI).